FLPP programma
- Projekts Nr. lzp-2023/1-0413 Katalītiskās hidrosililēšanas pielietojums no atjaunojamajiem resursiem iegūtu izejvielu valorizēšanā (2024 – 2026)
- Projekts Nr. lzp-2023/1-0312 Sēnīšu šūnapvalka pētījumi, izmantojot cietvielu kodolu magnētiskās rezonances spektroskopiju pie ātra griešanās režīma (2024 – 2026)
- Projekts Nr. lzp-2023/1-0308 Biomimētiskie mehānismi un ķīmiskā apstrāde mākslīgā zirnekļa zīda iegūšanai ar pielāgotām īpašībām (2024 – 2026)
- Projekts Nr. lzp-2023/1-0287: HMGCR enzīma deficīta izraisītās šūnu enerģijas metabolisma signālceļu izmaiņas (2024-2026)
- Projekts Nr. lzp-2023/1-0288 Metabolā terapija sirds mazspējas ar saglabātu izsviedes frakciju ārstēšanai (2023 – 2025)
- Projekts Nr. lzp-2022/1-0335 F-Nodālā sintēze: Monofluorētu viena oglekļa sintonu potenciāla izpēte (2023-2026)
- Projekts Nr. lzp-2021/1-0595: Ar helatēšanu stabilizētu organo-lambda3-bromānu elektroķīmiska iegūšana (2022-2024)
- Projekts Nr. lzp-2021/1-0593: Bioinerti sarveida polimēri kā teranostisķi metastazējoša krūts vēža terapijai (2022-2024)
- Projekts Nr. lzp-2021/1-0584: Karboanhidrāzes IX testa biosensora izstrāde vēža skrīningam (2022-2024)
- Projekts Nr. lzp-2021/1-0283: Krūts vēža mikrovides programmēšana ‘karstas’ imūnreakcijas izveidošanai audzējā (2022-2024)
- Projekts Nr. lzp-2021/1-0578: Sēru saturošu enantiotīru gamma-laktāmu bioizostēru sintēze (2022-2024)
- Projekts Nr. lzp-2021/1-0563: Sigma-1 receptors: jauns spēlētājs kardiometabolo slimību patoģenēzē un terapijā? (2022-2024)
Valsts Pētījumu programma (VPP)
Projekts Nr. VPP-EM-BIOMEDICĪNA-2022/1-0001 Valsts pētījumu programmas projekts biomedicīnā, medicīnas tehnoloģijās un farmācijā (2022-2024)
Eiropas Savienības finansēti projekti
- CLEAR: Cell Envelope Antibacterials (2024 – 2027)
- BIOCONNECT: Developing the Action Plan to Foster Baltic Region Innovation Ecosystem in Biotechnology and Synthetic Biology (2023 – 2024)
- AVITHRAPID: Antiviral Therapeutics for Rapid Response Against Pandemic Infectious Diseases (2024 -2028)
- Phototheraport: Luminescent Implants as Ports for Light-Based Therapies (2024 – 2026)
- TransPharm: Towards a more sustainable European pharmaceutical production of APIs (2022-2026)
- Fragment-Screen: From fragments to high affinity binders interfacing integrated structural biology, medicinal chemistry and artificial intelligence (2023-2026)
- NATALION: Natural Products Research at Latvian Institute of Organic Synthesis as a driver for Excellence in Innovation (2023-2027)
- Remote NMR (R-NMR): Moving NMR infrastructures to remote access capabilities (2022-2025)
- ISIDORe: Integrated Services for Infectious Disease Outbreak Research (2022 -2025)
- RM ROADMAP: Creating Framework Conditions for Research Management to Strengthen the European Research Area (2022-2025)
- Oligomers-MAS-NMR: Structure determination of amyloid oligomers, the pathogenic species in Alzheimer’s disease using fast MAS NMR and microfluidics (2021-2023)
- A4L_ACTIONS: Alliance for Life Sciences – From Strategies to Actions in Central and Eastern Europe (2021-2024)
- RISK-HUNT3R: Risk assessment of chemicals integrating human centric next generation testing strategies promoting the 3Rs (2021-2026)
- ALISE: Antibody Light-Induced Selectivity Enhancement (2021-2025)
- BBCE: Baltic Biomaterials Centre of Excellence (2020-2026)
- ERA4TB: European Regimen Accelerator for Tuberculosis (2020-2025)
- SPRINGBOARD: Springboard for excellence in advanced development of antibacterials (2020-2024)
- InterTAU: Integrative Structural Biology of Pathological tau Protein, an Appealing Therapeutic Target for Alzheimer´s Disease Modifying Drugs (2020-2023)
Estonia–Latvia programme 2021–2027 implemented under the European territorial cooperation goal (Interreg)
- EstLat Alliance in Drug Development – PharmaBoost (2023 -2025)
ERA-NET Projects |
- MURYXIN: The disulfide bond as a chemical tool in cyclic peptide antibiotics: engineering disulfide polymyxins and murepavadin (2023-2026)
- APRINHA: New Inhalation Formulations for Improved Delivery of Antimicrobials (2023-2025)
- TENTACLES: Temperature-responsive Nanogels for Targeted Delivery of MicroRNAs in Wound Healing and Tissue Regeneration Applications (2020-2023)
- EU-METAHEART: EUropean network to tackle METAbolic alterations in HEART failure (2023 – 2027)
- ML4NGP: Non-globular proteins in the era of Machine Learning (2022 – 2026)
- OneHealthdrugs: One Health drugs against parasitic vector borne diseases in Europe and beyond (2022-2026)
- EURESTOP: European Network for diagnosis and treatment of antibiotic-resistant bacterial infections (2022-2026)
- IMMUNO-model: Modelling immunotherapy response and toxicity in cancer (2022-2026)
- ANDRONET: European Andrology Network– research coordination, education and public awareness (2021-2025)
- TEATIME: Improving biomedical research by automated behaviour monitoring in the animal home-cage (2021-2025)
- VOICES: Making Early Career Investigators’ Voices Heard for Gender Equality (2021-2025)
- Mye-InfoBank: Converting molecular profiles of myeloid cells into biomarkers for inflammation and cancer (2021-2025)
- VascAgeNet: Network for Research in Vascular Ageing (2019 – 2024)
Citi projekti
Mutual fund Taiwan–Latvia–Lithuania |
- SYNERGISM: Synthesis and characterization of new organic emitters exibiting long-lived emissions for brain imaging (2024-2026)
- Structure determination of transthyretin amyloid fibris (2024 – 2026)
- Exploring Early Events in the Cold Denatured Apoptotic Bid Protein Using Sensitivity-Enhanced EPR and NMR (2023 – 2024)
- Synthesis and study of deep-blue TTF fluorescent emitters to exceed theoretical OLED external quantum efficiency reaching 15% (2023 – 2024)